Plant-based medicines and therapeutics finally are gaining significant traction with the medical establishment. After decades of close-mindedness, its about time.

Nico Pento discusses the increasing acceptance of plant-based medicines and therapeutics by the medical establishment, particularly psychedelics. After decades of close-mindedness, it is about time for this change. However he raises concerns about overregulation and how it may affect consumers’ ability to utilize natural substances.

Click Here For Full Article

About Bianchi & Brandt

Bianchi & Brandt offers a full suite of legal and strategic services tailored to the unique needs of complex industries, including cannabis and psychedelics, with a level of trust and expertise that is unmatched. With a deep bench of business law and regulatory specialists, the firm takes a holistic approach to client support across all operations. Bianchi & Brandt has served as a strategic partner to their clients and assisted not only with legal matters, but also risk management, compliance, M&A, and other business challenges. For over a decade, the firm has pursued its goal to help companies maximize results from founding through each new phase of growth. The Bianchi & Brandt team pride themselves on their long commitment to the industry and the deep client relationships forged by the firm’s founding partners. Learn more: bianchibrandt.com

Keep Reading

Laura Bianchi Featured in Exclusive Executive Interviews at Benzinga Cannabis Capital Conference

October 17, 2024

Laura Bianchi Featured in Benzinga Edge Exclusive “Cannabis Rescheduling Is Not Cure-All For Industry Problems: Experts Explain How Tax Tactics Could Hurt Marijuana Businesses In Long Run”

October 9, 2024

Bianchi & Brandt Nominated Second Year In a Row As Law Firm of the Year by Emjay Awards

October 1, 2024